Future trends in the treatment of brain tumours

European Journal of Cancer

Volumn 37, Issue 18, 2001, Pages 2297-2301

  Brandes, A A ^a   Lacombe, D ^b   Vecht, C ^c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b EORTC DATA CENTER   (Belgium)

^c EORTC Brain Tumor Group   (Netherlands)

Author keywords

Brain tumours; Editorial; EORTC; Review; Treatment

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; ALPHA INTERFERON; CARMUSTINE; CISPLATIN; CYTARABINE; DNA; DOXORUBICIN; HEMOGLOBIN; IRINOTECAN; MARIMASTAT; METHOTREXATE; PROCARBAZINE; RETINOIC ACID; RITUXIMAB; TAMOXIFEN; TEMOZOLOMIDE; THALIDOMIDE; TOPOTECAN; VINCRISTINE;

ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; DOSE RESPONSE; DRUG EFFICACY; FUTUROLOGY; GENE THERAPY; GLIOMA; HUMAN; LIFE EXPECTANCY; LYMPHOMA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSURGERY; SHORT SURVEY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CLINICAL TRIALS; FORECASTING; GLIOMA; HUMANS;

EID: 0035201132     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00301-X     Document Type: Editorial

References (32)

1. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
2. Phase III study comparing three cycles of infusional BCNU/cisplatin followed by radiation with radiation and concurrent BCNU for patients with newly diagnosed supratentorial glioblastoma multiforme (ECOG 2394-SWOG 9508)
3. Current approaches to radiation therapy for malignant gliomas
4. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
5. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer in newly diagnosed glioblastoma multiforme
6. Effect of disease burden on health-related quality of life in patients with malignant gliomas
7. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council Trial
8. Malignant glioma: Who benefits from adjuvant chemotherapy?
9. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
10. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
11. Daily temozolomide (TMZ) and concomitant radiation followed by adjuvant TMZ for newly diagnosed glioblastoma multiforme (GBM)
12. High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults
13. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
14. Procarbazine prior to and concomitant with BCNU in patients with glioblastoma at first relapse: A phase II study
15. Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
16. 6 -benzylguanine for patients with recurrent or progressive malignant glioma
17. 6 -alkylguanine-DNA alkyltransferase (AGAT), a mechanism of resistance to alkylators, with protracted low-dose oral schedules of temozolomide
18. Feasibility of a bid regimen of temodar in the treatment of recurrent malignant gliomas (RMG)
19. Protracted daily administration of temozolomide is feasible: A Phase I and pharmacokinetic-pharmacodynamic study
20. Protracted cyclic administration of temozolomide is feasible; a phase I, pharmacokinetic and pharmacodynamic study
21. Phase I trial of temozolomide using an extended continuous oral schedule
22. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma
23. Temozolomide chemotherapy in recurrent oligodendroglioma
24. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy
25. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844
26. Phase II treatment of anaplastic oligodendroglioma and low grade glioma with temozolomide
27. A phase II trial of primary chemotherapy with temozolomide in patients with low-grade cerebral gliomas
28. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas
29. Radiotherapy of the brain in elderly patients. Contra
30. Treatment for Primary CNS lymphoma: The next step
31. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma